IRAK2
Interleukin-1 receptor-associated kinase-like 2
Also known as: IRAK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43187
- Gene
- IRAK2
- Ensembl
- ENSG00000134070
- Chromosome
- 3
- Canonical length
- 625 aa
- Protein class
- Enzymes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
IRAK2 encodes the interleukin-1 receptor-associated kinase 2, one of two putative serine/threonine kinases that become associated with the interleukin-1 receptor (IL1R) upon stimulation. IRAK2 is reported to participate in the IL1-induced upregulation of NF-kappaB. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
625 residues, UniProt reviewed canonical sequence.
>O43187|IRAK2
1 MACYIYQLPS WVLDDLCRNM DALSEWDWME FASYVITDLT QLRKIKSMER VQGVSITREL
61 LWWWGMRQAT VQQLVDLLCR LELYRAAQII LNWKPAPEIR CPIPAFPDSV KPEKPLAASV
121 RKAEDEQEEG QPVRMATFPG PGSSPARAHQ PAFLQPPEED APHSLRSDLP TSSDSKDFST
181 SIPKQEKLLS LAGDSLFWSE ADVVQATDDF NQNRKISQGT FADVYRGHRH GKPFVFKKLR
241 ETACSSPGSI ERFFQAELQI CLRCCHPNVL PVLGFCAARQ FHSFIYPYMA NGSLQDRLQG
301 QGGSDPLPWP QRVSICSGLL CAVEYLHGLE IIHSNVKSSN VLLDQNLTPK LAHPMAHLCP
361 VNKRSKYTMM KTHLLRTSAA YLPEDFIRVG QLTKRVDIFS CGIVLAEVLT GIPAMDNNRS
421 PVYLKDLLLS DIPSSTASLC SRKTGVENVM AKEICQKYLE KGAGRLPEDC AEALATAACL
481 CLRRRNTSLQ EVCGSVAAVE ERLRGRETLL PWSGLSEGTG SSSNTPEETD DVDNSSLDAS
541 SSMSVAPWAG AATPLLPTEN GEGRLRVIVG READSSSEAC VGLEPPQDVT ETSWQIEINE
601 AKRKLMENIL LYKEEKVDSI ELFGPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRAK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 22 nTPM
- skeletal muscle: 16 nTPM
- urinary bladder: 15 nTPM
- tonsil: 11 nTPM
- liver: 10 nTPM
- lung: 10 nTPM
Single-cell type
- neutrophils: 783 nCPM
- urothelial cells: 464 nCPM
- monocytes: 315 nCPM
- cdc: 153 nCPM
- endometrial glandular cells: 143 nCPM
- macrophages: 132 nCPM
Immune cell
- NK-cell: 7.4 nTPM
- MAIT T-cell: 6 nTPM
- gdT-cell: 5.8 nTPM
- memory B-cell: 4.2 nTPM
- memory CD8 T-cell: 3.3 nTPM
- naive B-cell: 3.2 nTPM
Brain region
- cerebral cortex: 18 nTPM
- white matter: 17 nTPM
- pons: 13 nTPM
- hypothalamus: 12 nTPM
- medulla oblongata: 12 nTPM
- thalamus: 9.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical NF-kappaB signal transduction
- inflammatory response
- interleukin-1-mediated signaling pathway
- intracellular signal transduction
- lipopolysaccharide-mediated signaling pathway
- MyD88-dependent toll-like receptor signaling pathway
- negative regulation of canonical NF-kappaB signal transduction
- positive regulation of canonical NF-kappaB signal transduction
- protein phosphorylation
- regulation of cytokine-mediated signaling pathway
- response to interleukin-1
- Toll signaling pathway
- toll-like receptor 4 signaling pathway
Molecular functions
- ATP binding
- molecular adaptor activity
- protein heterodimerization activity
- protein homodimerization activity
- protein kinase activity
- signaling adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRAK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRAK2 as an antibody target. Whether an autoantibody or antibody against IRAK2 could matter depends on whether native IRAK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRAK2 is annotated at the cell surface, where native IRAK2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IRAK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...